Similar Articles
Rituximab experience in a resistant thrombotic thrombocytopenic purpura case
A. Beste Öztepe, Ercan Ersoy, Elif Ertürk, Sibel Demiral Sezer, Gülnur Görgün
DOI: 10.5606/fng.btd.2017.014
Issue: 2017, Volume 3 - Issue 2-3
0
2693
Investigating the clinical significance of platelet function disorder in patients with thrombocytopenia
Mehmet Can Uğur, Fatma Demet İnce, Hayrullah Durak, Burak Toprak, Burcu Bayrak, Cengiz Ceylan, Harun Akar
DOI: 10.5606/fng.btd.2016.005
Issue: 2016, Volume 2 - Issue 1
0
974
A rare cause of thrombocytopenia: Cyclic thrombocytopenia
Burcu Kurt, Yağız Meriç Altun, Neslihan Uslu, Reyhan Diz-Küçükkaya
DOI: 10.5606/fng.btd.2016.011
Issue: 2016, Volume 2 - Issue 1
0
1688
Evaluation of thrombotic thrombocytopenic purpura cases: A single-center experience
Cengiz Ceylan, Şeyma Hızarcı, Gülin Keskin, Damla Çağla Patır, Aybüke Olgun
DOI: 10.5606/fng.btd.2019.022
Issue: 2019, Volume 5 - Issue 3
2229
1291
COVID-19 and heparin-induced thrombocytopenia: Is there a relationship?
Mustafa Yılmaz, Can Özlü, Sevil Alkan, Hasan Hüseyin Gümüşçü
DOI: 10.5606/fng.btd.2022.32
Issue: 2022, Volume 8 - Issue 1
864
667